Press release
Healthcare Biomarkers Market is Determined to Cross US$ 56 Billion By 2022
Healthcare Biomarkers Market Share
Healthcare Biomarkers Market 2018
The Global Healthcare Biomarkers Market is expected to exceed more than US$ 56 billion by 2022 and will grow at a CAGR of more than 13% in the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche Diagnostics Ltd., Abbott Laboratories, Inc., Agilent Technologies, Inc., Epigenomics AG, GE Healthcare, Johnson & Johnson, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH, Qiagen N.V., and Merck& Co., Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The scope of the report includes a detailed study of global and regional markets for Global Healthcare Biomarkers Market with the reasons given for variations in the growth of the industry in certain regions.
Browse Full Report: https://www.marketresearchengine.com/reportdetails/healthcare-biomarkers-market
The Global Healthcare Biomarkers Market has been segmented as below:
By Product Analysis
• Consumable
• Software
• Services
By Type Analysis
• Safety biomarker
• Validation biomarker
• Efficacy biomarker
By Application Analysis
• Diagnostics development
• Personalized medicine
• Drug discovery & development
• Disease risk assessment
By Disease indication Analysis
• Cancer
• Neurological disorders
• Cardiovascular disorders
• Immunological disorders
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
This report provides:
1) An overview of the global market for Healthcare Biomarkers and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Healthcare Biomarkers.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The Global Healthcare Biomarkers Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
Request Sample Report: https://www.marketresearchengine.com/reportdetails/healthcare-biomarkers-market
Table of Contents
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Biomarkers Market, By Product
6.1 Introduction
6.2 Consumables
6.3 Services
6.4 Software
7 Biomarkers Market, By Type
7.1 Introduction
7.2 Safety Biomarkers
7.3 Efficacy Biomarkers
7.3.1 Predictive Biomarkers
7.3.2 Surrogate Biomarkers
7.3.3 Pharmacodynamic Biomarkers
7.3.4 Prognostic Biomarkers
7.4 Validation Biomarkers
8 Biomarkers Market, By Application
9 Biomarkers Market, By Disease Indication
10 Biomarkers Market, By Region
11 Competitive Landscape
12 Company Profiles
12.1 Qiagen N.V.
12.2 Perkinelmer, Inc.
12.3 Merck Millipore
12.4 Bio-Rad Laboratories, Inc.
12.5 Enzo Biochem, Inc.
12.6 EKF Diagnostics Holdings, Inc.
12.7 Meso Scale Diagnostics, LLC.
12.8 Biosims Technologies Sas
12.9 Cisbio Bioassays
12.10 Signosis, Inc.
About Us
Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Healthcare Biomarkers Market is Determined to Cross US$ 56 Billion By 2022 here
News-ID: 992389 • Views: …
More Releases from (MRE) Report
Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
New York, March 26, 2018:
Weight Management Market 2018
The Global Weight Management Market is expected to exceed more than US$ 442.0 Billion by 2025 at a CAGR of 8.0% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets on Global Weight Management Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…
Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
New York, March 26, 2018:
Home Healthcare Market 2018
The Global Home Healthcare Market is expected to exceed more than US$ 300.7 Billion by 2022 at a CAGR of 7.4% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets on Global Home Healthcare Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…
Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
New York, March 26, 2018:
Healthcare 3D Printing Market 2018
The Global Healthcare 3D Printing Market is expected to exceed more than US$ 4 Billion by 2022 at a CAGR of 21.0% in the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include 3D Systems, Arcam AB, Renishaw PLC., EoS…
Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
New York, March 26, 2018:
Tumor Ablation Market 2018
The Global Tumor Ablation Market is expected to exceed more than US$ 650 Million by 2022 at a CAGR of 12.0% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets for Global Tumor Ablation Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…
More Releases for Biomarkers
Predisposition Biomarkers Market - Rapid Growth at Deep Value Price from 2020-20 …
"The new report has been added by qyresearch.com to provide detailed insight into the global Predisposition Biomarkers market. The study will help to get a better understanding about the Predisposition Biomarkers industry competitors, a channel for the distribution, Predisposition Biomarkers growth potential, potentially disruptive trends, Predisposition Biomarkers industry product innovations, market size value/volume (regional/country level, Predisposition Biomarkers industry segments), market share of top players/products.
Due to the pandemic, we have included…
3rd World Biomarkers Summit
We cordially invite you to the 3rd World Biomarkers Summit to be held at Rome, Italy on April 22-23, 2020. The 2020 edition of the Biomarkers conference will move forward with the theme “Biomarker as a future protagonist”. Biomarkers 2020 concentrates on procuring emerging researches in the sector of medicine and health brought to us via applications of biomarkers. Scientists, Young researchers, pharmaceutical industrialists and medical professionals are expected to…
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular…
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.
The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report…
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help…
Biomarkers Summit
SMi present their 4th annual conference on
Biomarkers Summit
Monday 31st January & Tuesday 1st February 2011
Crowne Plaza The-City, London, UK
Don’t Miss Out - Visit to register your place today
http://www.smi-online.co.uk/preclinical-biomarkers.asp
Sponsored by
Caprotec
Cell Signalling Technology
GVK Bio
Selventa
Millipore Quest Diagnostics
RBM
SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out…
